Orchid Pharma Limited
NSE:ORCHPHARMA.NS
784.9 (INR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8,190.663 | 6,658.984 | 5,595.574 | 4,500.604 | 4,838.015 | 5,999.805 | 6,829.833 | 7,965.041 | 8,594.999 | 11,644.066 | 12,984.665 | 12,278.659 | 17,923.234 | 17,817.903 | 13,434.534 | 12,968.489 | 13,009.639 | 9,638.23 | 9,366.306 | 7,223.384 | 6,699.945 |
| Cost of Revenue
| 5,031.833 | 4,012.544 | 3,270.92 | 2,413.023 | 2,240.196 | 5,752.001 | 3,731.628 | 7,178.441 | 7,507.089 | 10,141.603 | 11,699.235 | 6,552.443 | 9,086.598 | 10,327.437 | 8,395.459 | 5,856.19 | 4,793.181 | 3,536.372 | 4,284.109 | 3,331.213 | 5,748.124 |
| Gross Profit
| 3,158.83 | 2,646.44 | 2,324.654 | 2,087.581 | 2,597.819 | 247.804 | 3,098.205 | 786.6 | 1,087.91 | 1,502.463 | 1,285.43 | 5,726.216 | 8,836.636 | 7,490.466 | 5,039.075 | 7,112.299 | 8,216.458 | 6,101.858 | 5,082.197 | 3,892.171 | 951.821 |
| Gross Profit Ratio
| 0.386 | 0.397 | 0.415 | 0.464 | 0.537 | 0.041 | 0.454 | 0.099 | 0.127 | 0.129 | 0.099 | 0.466 | 0.493 | 0.42 | 0.375 | 0.548 | 0.632 | 0.633 | 0.543 | 0.539 | 0.142 |
| Reseach & Development Expenses
| 70.937 | 63.621 | 66.263 | 48.097 | 119.285 | 139.618 | 177.333 | 376.014 | 316.51 | 401.037 | 580.332 | 0 | 693.287 | 259.997 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 84.264 | 87.865 | 88.986 | 128.989 | 239.875 | 142.949 | 173.039 | 206.581 | 122.881 | 0 | 224.417 | 0 | 386.597 | 1,284.28 | 0 | 0 | 0 | 3,336.047 | 2,707.663 | 0 | 0 |
| Selling & Marketing Expenses
| 238.563 | 143.363 | 222.617 | 134.55 | 92.042 | 103.434 | 220.963 | 261.886 | 277.314 | 0 | 370.144 | 0 | 632.597 | 550.579 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 322.827 | 231.228 | 309.031 | 263.507 | 313.14 | 246.383 | 394.002 | 468.467 | 400.195 | 1,396.826 | 1,536.102 | 0 | 1,019.194 | 1,834.859 | 0 | 0 | 0 | 3,336.047 | 2,707.663 | 0 | 0 |
| Other Expenses
| 0 | 2,095.685 | 2,281.886 | 2,285.265 | 2,866.433 | 3,238.717 | 3,421.918 | 4,040.2 | 3,450.975 | -59.8 | 0 | 5,972.021 | 4,769.158 | 3,242.898 | -2,081.976 | 5,885.963 | 5,110.803 | 847.33 | 845.986 | 2,956.808 | 96.284 |
| Operating Expenses
| 2,422.106 | 2,390.534 | 2,657.142 | 2,596.901 | 3,298.858 | 3,624.718 | 3,993.253 | 4,884.681 | 4,167.68 | 1,797.862 | 2,155.653 | 5,972.021 | 6,481.639 | 5,337.754 | -2,081.976 | 5,885.963 | 5,110.803 | 4,183.377 | 3,553.649 | 2,956.808 | 96.284 |
| Operating Income
| 784.691 | 296.69 | -338.899 | -504.944 | -701.039 | -736.564 | -895.048 | -1,093.147 | -3,212.589 | -47.265 | -870.16 | -245.805 | 2,626.578 | 2,152.711 | 7,121.051 | 1,226.336 | 3,105.655 | 1,918.481 | 1,528.548 | 935.346 | 855.537 |
| Operating Income Ratio
| 0.096 | 0.045 | -0.061 | -0.112 | -0.145 | -0.123 | -0.131 | -0.137 | -0.374 | -0.004 | -0.067 | -0.02 | 0.147 | 0.121 | 0.53 | 0.095 | 0.239 | 0.199 | 0.163 | 0.129 | 0.128 |
| Total Other Income Expenses Net
| 134.761 | 255.779 | -230.088 | -447.545 | 4.121 | 1,430.643 | -3,094.582 | -4,344.612 | 248.955 | -2,544.259 | -2,812.93 | -2,780.895 | -1,872.216 | -437.064 | -2,422.704 | -1,564.501 | -820.005 | -992.915 | -878.448 | -735.458 | -583.789 |
| Income Before Tax
| 919.452 | 552.469 | -568.987 | -952.489 | -696.918 | 694.079 | -3,989.63 | -5,437.759 | -2,963.634 | -2,591.524 | -3,683.09 | -3,026.7 | 754.362 | 1,715.647 | 4,698.347 | -338.165 | 2,285.65 | 925.566 | 650.1 | 199.888 | 271.748 |
| Income Before Tax Ratio
| 0.112 | 0.083 | -0.102 | -0.212 | -0.144 | 0.116 | -0.584 | -0.683 | -0.345 | -0.223 | -0.284 | -0.247 | 0.042 | 0.096 | 0.35 | -0.026 | 0.176 | 0.096 | 0.069 | 0.028 | 0.041 |
| Income Tax Expense
| -31.191 | 21.535 | 35.227 | 0 | -0.1 | 0 | -461.944 | -483.422 | -172.507 | -1,276.39 | -83.484 | -272.958 | -220.421 | 153.779 | 1,305.808 | 151.734 | 532.251 | 140.078 | 77.1 | -21.033 | 19.5 |
| Net Income
| 921.665 | 463.183 | -19.512 | -1,165.3 | -1,310.701 | 694.079 | -3,527.686 | -4,954.337 | -2,791.127 | -1,311.019 | -3,720.182 | -2,753.742 | 974.783 | 1,561.868 | 3,392.539 | -489.899 | 1,753.399 | 785.488 | 573 | 220.921 | 250.359 |
| Net Income Ratio
| 0.113 | 0.07 | -0.003 | -0.259 | -0.271 | 0.116 | -0.517 | -0.622 | -0.325 | -0.113 | -0.287 | -0.224 | 0.054 | 0.088 | 0.253 | -0.038 | 0.135 | 0.081 | 0.061 | 0.031 | 0.037 |
| EPS
| 19.06 | 11.35 | -0.48 | -28.55 | -14.75 | 7.8 | -39.65 | -55.69 | -32.07 | -3,905.89 | -11,509.89 | -39.09 | 13.84 | 22.17 | 48.16 | -7.14 | 26.93 | 11.95 | 10.27 | 4.53 | 5.15 |
| EPS Diluted
| 19.06 | 11.35 | -0.48 | -28.55 | -14.75 | 7.8 | -39.65 | -55.69 | -32.07 | -3,905.89 | -11,509.36 | -39.09 | 13.67 | 18.32 | 38.21 | -5.46 | 17.91 | 10.75 | 9.43 | 4.3 | 0 |
| EBITDA
| 1,419.179 | 1,429.359 | 635.819 | 658.739 | 523.945 | 2,060.392 | 359.979 | -559.556 | 1,431.48 | 3,531.422 | 1,481.001 | 1,325.771 | 4,051.48 | 4,218.21 | 8,670.047 | 2,566.261 | 4,112.439 | 2,769.374 | 2,386.724 | 1,573.176 | 1,455.627 |
| EBITDA Ratio
| 0.173 | 0.215 | 0.114 | 0.146 | 0.108 | 0.343 | 0.053 | -0.07 | 0.167 | 0.303 | 0.114 | 0.108 | 0.226 | 0.237 | 0.645 | 0.198 | 0.316 | 0.287 | 0.255 | 0.218 | 0.217 |